FDA backs Pfizer COVID-19 boosters for seniors, high-risk

The US moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of extra shots, Associated Press reported. The FDA authorized booster doses...